{"product_id":"fda-fda-correspondence-on-ezricare-artificial-tears-contamination","title":"FDA: FDA Correspondence on EzriCare Artificial Tears Contamination","description":"\u003cb\u003eRequest Content:\u003c\/b\u003e Correspondence between FDA staff and representatives of Global Pharma Healthcare, EzriCare, or Delsam Pharma regarding the issues raised in FDA’s warning about EzriCare Artificial Tears contamination.","brand":"FDA","offers":[{"title":"Default Title","offer_id":50778865369252,"sku":"FDAFT033","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/fda-fda-correspondence-on-ezricare-artificial-tears-contamination","provider":"FOIA Document Source","version":"1.0","type":"link"}